SOURCE: Equity News Circuit

Equity News Circuit

May 14, 2013 08:15 ET

Free Research Reports on BIIB, KORS, PERI and SSYS Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwired - May 14, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Biogen Idec Inc. (NASDAQ: BIIB) shares spiked approximately 3.5 percent on volume of over 1.0 million shares traded Monday. The company announced that the FDA has started its review of Biogen's hemophilia A treatment. Biogen's hemophilia B treatment, Alprolix, review began in March.

Find out more about Biogen Idec including full access to the free equity report at: www.BedfordReport.com/BIIB

Michael Kors Holdings Ltd. (NYSE: KORS) shares have gained approximately 20.0 year-to-date. Kimberly Greenberger has recently added the company to Morgan Stanley's "Best Ideas" list, citing the company's long term earnings potential. Michael Kors is scheduled to release fourth quarter and fiscal 2013 results on Wednesday, May 29th.

Find out more about Michael Kors including full access to the free equity report at: www.BedfordReport.com/KORS

Perion Network Ltd. (NASDAQ: PERI) shares surged over 11 percent on more than ten times the average daily volume Monday. The company reported earnings of $2.9 million, or $0.22 per share, for the first quarter of 2013, compared to earnings of just $370,000, or $0.04 per share, a year ago.

Find out more about Perion Network including full access to the free equity report at: www.BedfordReport.com/PERI

Stratasys, Ltd. (NASDAQ: SSYS) shares have spiked approximately 10.0 percent in the last month. The company reported revenues of $97.2 million for the first quarter of 2013, more than double the revenues of $45.0 million posted in the year ago quarter. According to FactSet analysts had expected revenues of $98.3 million.

Find out more about Stratasys including full access to the free equity report at: www.BedfordReport.com/SSYS

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information